PROF DR BRECHT CARDOEN. Introduction

Transcription

1 PROF DR BRECHT CARDOEN Introduction

2 If we think about uncertainty Future 2 Future 4 Future 1 Future 3

3 Scenario analysis

4 Scenario analysis Technological breakthrough Impact demand for s Insurer and private care gets to forefront, next to public funding Power of physician associations Little to no networking Two-speeds? Solidarity? Privileged care

5 Scenario analysis Technological breakthrough Impact demand for s Insurer and private care gets to forefront, next to public funding Power of physician associations Little to no networking Two-speeds? Solidarity? Privileged care Connected care Networks at regional and national level (data) Specialization and collaboration Standardization More extra-muros care Towards value Limited enabling innovation, unless supported by industry

6 Scenario analysis Technological breakthrough Impact demand for s Insurer and private care gets to forefront, next to public funding Power of physician associations Little to no networking Two-speeds? Solidarity? Privileged care From curative to preventive Substantial extra muros activity, but well-embedded in network Focus on and quality Data-supported decision making (AI?) High patient involvement Health care Connected care Networks at regional and national level (data) Specialization and collaboration Standardization More extra-muros care Towards value Limited enabling innovation, unless supported by industry

7 Framing for the future Technological breakthrough Impact demand for s Insurer and private care gets to forefront, next to public funding Power of physician associations Little to no networking Two-speeds? Solidarity? Privileged care From curative to preventive Substantial extra muros activity, but well-embedded in network Focus on and quality Data-supported decision making (AI?) High patient involvement Health care Connected care Networks at regional and national level (data) Specialization and collaboration Standardization More extra-muros care Towards value Limited enabling innovation, unless supported by industry

8 PROF DR KRIS VANHAECHT Session Title: The quality of care and its impact on the competition between healthcare providers Kris Vanhaecht is Assistant Professor in Quality Management in Healthcare at KULeuven. Kris is coordinator of the research line on quality & patient safety of the new KULeuven Institute for Healthcare Policy (Leuvens Instituut voor Gezondheidszorgbeleid LIGB). Currently, he is the Secretary General of the European Pathway Association and is international coordinator of international studies on care pathways. He is part-time academic policy advisor to the management team and the quality department of Leuven University Hospitals and also collaborates with Dutch hospitals on quality and leadership development. 8

9 Framing for the future Technological breakthrough Impact demand for s Insurer and private care gets to forefront, next to public funding Power of physician associations Little to no networking Two-speeds? Solidarity? Privileged care From curative to preventive Substantial extra muros activity, but well-embedded in network Focus on and quality Data-supported decision making (AI?) High patient involvement Health care Connected care Networks at regional and national level (data) Specialization and collaboration Standardization More extra-muros care Towards value Limited enabling innovation, unless supported by industry

10 PROF DR CAROL PROPPER Session: Hospitals and competition: a view from the NHS and its reforms Carol is a Professor of Economics at Imperial College Business School in the Organisation & Management Group. Carol joined Imperial College Business School as Professor of Economics and Head of the new Health Management Group on 1 October She also holds an appointment at the University of Bristol. Carol was Senior Economic Advisor to NHS Executive on Regulation of the NHS Internal Market , Co-Director of the Centre for the Analysis of Social Exclusion at London School of Economics from , Co-Director and Director of the Centre for Market and Public Organisation from , and chaired the ESRC research grants board until Carol has been awarded a CBE for her s to social science the accolade recognises Carol s research into public economics and economics of healthcare as well as her work with colleagues from other social science and medical disciplines. 10

11 PROF DR FILIP DEWALLENS Session: How does a growing level of clustering between doctors lead to more intermediate competition on a regional level? Filip Dewallens is Professor Hospital Governance and Law at KU Leuven & Universiteit Antwerpen, and Managing Partner at Dewallens & Partners law firm. He has been a visiting professor at the University of Ljubljana (Slovenia). Since 1996, Filip has also been the president of the Flemish Association of Health Law. Between 2004 and 2009, Filip was a member of the board of ZiekenhuisNetwerk Antwerpen, Belgium s largest hospital group. Since 2013, Filip has been a member of KU Leuven s board of governors. On the international level, Filip has undertaken consulting work for the IMF, the World Bank (Macedonia 1997 and 2007, Slovenia 2004), and the Council of Europe (Montenegro 2008, Serbia 2009). 11